SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kronox Lab Sciences - Quaterly Results

15 Nov 2024 Evaluate
The revenue zoomed 18.24% to Rs. 248.59 millions for the quarter ended September 2024 as compared to Rs. 210.24 millions during the corresponding quarter last year.The company has announced a 48.77% increase in its profits to Rs . 64.73  millions for the  quarter ended September 2024 compared to Rs. 43.51 millions in the corresponding quarter in the previous year.Operating profit surged to 91.65 millions from the corresponding previous quarter of 63.51 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 248.59 210.24 18.24 500.52 469.76 6.55 898.62 955.78 -5.98
Other Income 3.61 4.94 -26.92 7.93 7.37 7.60 15.78 19.20 -17.81
PBIDT 91.65 63.51 44.31 178.05 151.12 17.82 298.96 236.31 26.51
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.93 0.00
PBDT 91.65 63.51 44.31 178.05 151.12 17.82 298.96 235.38 27.01
Depreciation 3.42 3.79 -9.76 6.74 6.97 -3.30 12.89 14.97 -13.89
PBT 88.23 59.72 47.74 171.31 144.15 18.84 286.07 220.41 29.79
TAX 23.50 16.21 44.97 45.08 36.82 22.43 72.57 56.38 28.72
Deferred Tax 0.95 0.63 50.79 0.86 -0.52 -265.38 -0.92 -0.84 9.52
PAT 64.73 43.51 48.77 126.23 107.33 17.61 213.50 164.03 30.16
Equity 371.04 371.04 0.00 371.04 371.04 0.00 371.04 371.04 0.00
PBIDTM(%) 36.87 30.21 22.05 35.57 32.17 10.58 33.27 24.72 34.56

Kronox Lab Sciences Share Price

139.20 -1.64 (-1.16%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×